News

Hosted on MSN3m
Bristol Myers to pay $1.5 billion upfront for BioNTech cancer drug partnership
(Reuters) -Bristol Myers Squibb will pay $1.5 billion upfront to partner with Germany's BioNTech on an experimental cancer ...